US4187852A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Synthetic elastomeric insoluble cross-linked polypentapeptide
Assignee: UAB RESEARCH FOUNDATION NON-PROFIT CORP
•
Filing: 1978-08-14
•
Granted: 1980-02-12
•
Expires: 1998-08-14
Abstract
Abstract An insoluble cross-linked polypentapeptide is totally synthesized by preparing two modified linear polypentapeptides patterned on the polypentapeptide from the pentapeptide (Val 1 -Pro 2 -Gly 3 -Val 4 -Gly 5 ) one of the repeating peptide sequences contained in tropoelastin, the precursor protein of the core of the elastic fiber of the vascular wall, and by cross-linking the modified polypentapeptides. One of the intermediate polypentapeptides is modified by replacing a portion of at least one of the amino acid residues with the residue of an amino acid having more than one amino function and the other is modified by replacing a portion of at least one of the amino acid residues with the residue of an amino acid having more than one carboxyl function, to provide free amino groups on the one intermediate and free carboxyl groups on the other for interreaction in the presence of a suitable cross-linking agent. The resulting cross-linked insoluble polypentapeptide is elastomeric in nature and capable of calcification by withdrawing calcium ions from a serum medium, thus making it useful as a calcifiable matrix for the formation of an artificial bone structure. The calcifiable material can be treated to make it useful in artificial vascular wall formation.
Inventors
- 👤 Dan W. Urry
- 👤 Kouji Okamoto
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 01:55
CPC Classifications
C; C08; C08G; C08G69/00; C08G69/02; C08G69/08; C08G69/10; A; A61; A61F; A61F2/00; A61F2/02; A61F2/04; A61F2/06; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
183 words
A method of forming and repairing bone structure in animals, comprising implanting in the animal body as a calcifiable matrix a synthetic elastomeric water-insoluble polypentapeptide prepared by cross-linking a first linear polypentapeptide and a second linear polypentapeptide, said first linear polypentapeptide being one consisting essentially of first pentapeptide units (Val 1 Pro 2 Gly 3 Val 4 Gly 5 ) and second pentapeptide units in which one of the amino acid residues of said first pentapeptide units is replaced by the residue of an amino acid having more than one amino function and said second linear polypentapeptide being one consisting essentially of first pentapeptide units (Val 1 Pro 2 Gly 3 Val 4 Gly 5 ) and second pentapeptide units in which one of the amino acid residues of said first pentapeptide unit is replaced by the residue of an amino acid having more than one carboxyl function, said cross-linking being effected by the presence of an effective amount of an agent which causes reaction between free amino functions of said first linear polypentapeptide and free carboxyl functions of said second linear polypentapeptide.
Claim 2
Independent Claim
183 words
A method of forming and repairing bone structure in animals, comprising implanting in the animal body as a calcifiable matrix a synthetic elastomeric water-insoluble polypentapeptide prepared by cross-linking a first linear polypentapeptide and a second linear polypentapeptide, said first linear polypentapeptide being one consisting essentially of first pentapeptide units (Val 1 Pro 2 Gly 3 Val 4 Gly 5 ) and second pentapeptide units in which one of the amino acid residues of said first pentapeptide units is replaced by the residue of an amino acid having more than one amino function and said second linear polypentapeptide being one consisting essentially of first pentapeptide units (Val 1 Pro 2 Gly 3 Val 4 Gly 5 ) and second pentapeptide units in which one of the amino acid residues of said first pentapeptide unit is replaced by the residue of an amino acid having more than one carboxyl function, said cross-linking being effected by the presence of an effective amount of an agent which causes reaction between free amino functions of said first linear polypentapeptide and free carboxyl functions of said second linear polypentapeptide.
Claim 3
Dependent Claim
185 words
An artificial vascular wall material, comprising a synthetic elastomeric water-insoluble polypentapeptide prepared by cross-linking a first linear polypentapeptide and a second linear polypentapeptide, said first linear polypentapeptide being one consisting essentially of first pentapeptide units (Val 1 Pro 2 Gly 3 Val 4 Gly 5 ) and second pentapeptide units in which one of the amino acid residues of said first pentapeptide units is replaced by the residue of an amino acid having more than one amino function and said second linear polypentapeptide being one consisting essentially of first pentapeptide units (Val 1 Pro 2 Gly 3 Val 4 Gly 5 ) and second pentapeptide units in which one of the amino acid residues of said first pentapeptide unit is replaced by the residue of an amino acid having more than one carboxyl function, said cross-linking being effected by the presence of an effective amount of an agent which causes reaction between free amino functions of said first linear polypentapeptide and free carboxyl functions of said second linear polypentapeptide, said water-soluble polypentapeptide being inactivated against calcification by reaction with a glyco protein or a proteoglycan.
Claim 4
Dependent Claim
185 words
An artificial vascular wall material, comprising a synthetic elastomeric water-insoluble polypentapeptide prepared by cross-linking a first linear polypentapeptide and a second linear polypentapeptide, said first linear polypentapeptide being one consisting essentially of first pentapeptide units (Val 1 Pro 2 Gly 3 Val 4 Gly 5 ) and second pentapeptide units in which one of the amino acid residues of said first pentapeptide units is replaced by the residue of an amino acid having more than one amino function and said second linear polypentapeptide being one consisting essentially of first pentapeptide units (Val 1 Pro 2 Gly 3 Val 4 Gly 5 ) and second pentapeptide units in which one of the amino acid residues of said first pentapeptide unit is replaced by the residue of an amino acid having more than one carboxyl function, said cross-linking being effected by the presence of an effective amount of an agent which causes reaction between free amino functions of said first linear polypentapeptide and free carboxyl functions of said second linear polypentapeptide, said water-soluble polypentapeptide being inactivated against calcification by reaction with a glyco protein or a proteoglycan.
Claim 5
Dependent Claim
29 words
A method of repairing the vascular system in animals, comprising replacing a damaged portion of said system with a shaped artificial vascular wall material as claimed in claim 2.
References Cited (Backward Citations)
US4093677A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-02-11 | 1983-08-13 | 1984-02-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-02-11 | 1987-08-13 | 1988-02-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-02-11 | 1991-08-13 | 1992-02-12 | $7700.00 | Window Closed / Lapsed |